PNC Financial Services Group’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.66K Buy
268
+75
+39% +$924 ﹤0.01% 4744
2026
Q2
$2.54K Sell
193
-637
-77% -$7.92K ﹤0.01% 4600
2026
Q1
$9.4K Buy
830
+90
+12% +$991 ﹤0.01% 3983
2025
Q4
$5.93K Sell
740
-2,174
-75% -$50.8K ﹤0.01% 4161
2025
Q3
$140K Buy
+2,914
New +$64.7K ﹤0.01% 2560
2023
Q4
– Sell
-20
Closed -$370 – 4702
2023
Q3
$370 Hold
20
– – ﹤0.01% 4491
2023
Q2
$346 Hold
20
– – ﹤0.01% 4626
2023
Q1
$503 Buy
+20
New +$2.28K ﹤0.01% 4525
2022
Q2
– Sell
-4
Closed – – 4616
2022
Q1
$0 Buy
+4
New +$764 ﹤0.01% 4622
2021
Q4
– Sell
-2
Closed -$1K – 4533
2021
Q3
$1K Buy
+2
New +$787 ﹤0.01% 4204
2021
Q2
– Sell
-4
Closed -$2K – 4240
2021
Q1
$2K Buy
+4
New +$7.77K ﹤0.01% 3957

Other funds holding KRRO

PNC Financial Services Group's KRRO Position: Q3 2026 in Review

PNC Financial Services Group increased its Korro Bio (KRRO) stake by 39% in Q3 2026, buying an estimated $924 and bringing the position to 268 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #4744.

PNC Financial Services Group first reported a position in KRRO in Q1 2021 and has held it in 11 quarters since. The position peaked at $140K in Q3 2025. 105 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • PNC Financial Services Group held 268 shares of Korro Bio worth $2.66K as of Q3 2026.
  • PNC Financial Services Group bought 75 Korro Bio shares in Q3 2026, an estimated $924.
  • Korro Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4744 holding.
  • PNC Financial Services Group first reported a position in Korro Bio in Q1 2021 and has held it in 11 quarters since.
  • PNC Financial Services Group's Korro Bio position peaked at $140K in Q3 2025.
  • 105 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.